Search Results
Site Search
Industry Updates From the Nation's Capital: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss...
The laboratory's role in spurring innovation: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Dendritic Cell Enumeration Test: Amir Sadighi Akha, M.D., D.Phil. - Insights
Amir Sadighi Akha, M.D., D.Phil., lab section director for Mayo Clinic's Cellular and Molecular Immunology Laboratory, joins this episode of the "Answers From the Lab" podcast. Dr. Sadighi Akha and Bobbi Pritt, M.D., discuss dendritic cell...
Soaring Interest in Health Care Professions: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this...
Omicron Variant: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
The State of COVID-19 Now: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Virus outlook heading into fall: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Looking at the big picture: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Triple-demic update and the future of at-home testing: Dr. Bill Morice - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., provide an update on this year’s triple-demic of respiratory viruses, discuss the future of at-home testing, and preview future pandemic...
Regulation of Lab Developed Tests: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for a leadership update with Bobbi Pritt, M.D....
New Masking Guidelines: Dr. Bill Morice - Insights
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
COVID-19 Variants: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this...
Congressional and Federal Updates: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They...
The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...
Leading diagnostics into the future: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Ensuring quality in the lab: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Advocating for lab legislation: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Staying safe during the holidays: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Shifting from pandemic to endemic: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi...
Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They...
Nonradioactive assay helps diagnose heparin reaction - Insights
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
Mitochondrial Disease [Test in Focus] - Insights
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision...
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' pediatric autoimmune/CNS testing can better guide the treatment of autoimmune neurological diseases in children. The tailored evaluation covers only biomarkers...
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
Novel panel identifies toxins linked to asthma and GI diseases - Insights
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Focused lung panel informs the use of targeted cancer therapies - Insights
Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.
What's New in Health Care Reform: Feb. 6 - Insights
Top highlights include: New U.S. experiments aim to create gene-edited human embryos, death-cap mushrooms are spreading across North America, daily exercise has been shown to lower blood pressure, scans show female brains remain youthful as...
December 2022 - Clinical Informatics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Informatics.
CPT codes and LOINC update: October 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of October.
What's New in Health Care Reform: Feb. 13 - Insights
Top highlights include: College education doesn't protect against Alzheimer's, A.I. shows promise as a physician assistant, how machine learning is crafting precision medicine, CVS introduces new concept store with more health care, and...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
Pathways Case Studies: December 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Bone and Soft Tissue Pathology,...
https://www.mayocliniclabs.com/test-notifications/cpt-codes.php?format=excel
cpt_code_updates Mayo Test ID Test Name CPT Code GLSF Glucose, Spinal Fluid 82945 A1AF Alpha-1-Antitrypsin, Random, Feces 82103 TPSF Protein, Total, Spinal Fluid 84157 HCO3 Bicarbonate, Serum 82374 TIBC Total Iron Binding Capacity,...